Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Shabbir, S. Jenn, S. Tzotzos, B. Fischer, H. Pietschmann, H. Fischer, R. Lucas, R. Lemmens-Gruber (Vienna, Austria; Georgia, United States Of America). Investigation of the feasibility of manufacturing a spray-dried formulation of the synthetic peptide, AP301. Eur Respir J 2014; 44: Suppl. 58, 962

Member's Comments

No comment yet.

Related content which might interest you: In vitro characterization of a novel inhaled PI3Kd inhibitor LAS194223 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Development of a lung slice methodology to study the mechanisms of lung uptake and lysosomal trapping Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Pharmaceutical development of a liquid formulation for pulmonary application of a peptide Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 The performance of a new vibrating mesh prototype nebulizer for inhaled biodrugs Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Effectively targeting small airways using controlled inhalation for peripheral corticosteroid deposition Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Changes in exhaled volatile organic compound profile after breakfast: Implications for protocol development Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Development of a new bronchial provocation test with dry powder adenosine Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 In vitro profile of the new inhaled pan-JAK inhibitor LAS194046 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Instilled surfactant stimulates the expression of surfactant protein A, ameliorating the inhalation injury in rats Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Non-invasive assessment of VQ - should we use a two compartment or three compartment model? Source: International Congress 2014 – New aspects of lung function testing in children Year: 2014 Are extra-fine particles from dry powder inhalers likely to improve lung deposition? Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Inhaled silver nanoparticles induce pulmonary oxidative injury and inflammation: Differential effects between rat strains Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Lipid derivatives of dopamine and respiration Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 The novel elastase inhibitor BAY 85-8501: Bioavailability and Food effect study to evaluate pharmacokinetics of tablet formulations Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Effect of the combination of doxofylline and montelukast on LPS-induced leukocyte migration to the lung Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Biopharmaceutical and chemical compatibility of the combination of salbutamol hemisuccinate and methatropium iodide Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Systemic exposure and lung bioavailability across two different dose strengths of CHF5993 a novel Triple pMDI Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Effects of using a mask vs mouthpiece on the multiple breath inert gas washout technique Source: International Congress 2015 – Lung function: waiting to exhale... Year: 2015 Mesoporous silica-based nanoparticles for targeted delivery of proteasome inhibitors to the lung Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Pulmonary effects of frying vegetable oils: An experimental study Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014